NCI Early Drug Development (Overview)


The NCI CTEP Early Drug Development Meeting is held annually to enhance communication between NCI and the network of ETCTN investigators that conduct CTEP-sponsored early phase clinical trials. The meeting is open to academic, government, and pharmaceutical clinical investigators and related health care personnel (e.g., nurses, statisticians, translational scientist, etc.) involved in CTEP funded oncology early drug development. The focus of the meeting is on prioritizing investigational agent selection and targeting, novel trial designs, and development and implementation of translational studies, as well as on new therapeutic and imaging modalities. The data presented at the meeting is considered a private communication, and the information should not be disseminated for public use.

The Michaele C. Christian Oncology Development Award, given annually, to a mid-career investigator, will be presented at the end of the meeting on Friday, September 27, 2024.

The meeting this year will be a hybrid format (virtual and in-person). Information on how to log on will be sent to all registered attendees. CME credit will not be offered as part of this meeting.


2024 NCI Early Drug Development Meeting:

Date: September 26, 2024

Time: 9:00 a.m.–4:30 p.m. (ET)

Date: September 27, 2024

Time: 9:00 a.m.–12:00 p.m. (ET)


Virtual Webex: Link will be sent upon registration

In-person location:  NCI, Shady Grove, Conference Room T406-410

Registration deadline: September 25, 2024